ACT-AEC First Annual Meeting

At the ACT-AEC First Annual Meeting, ACT-AEC invited 48 Canadian biotechnology companies to present their work to members of the consortium. ACT-AEC is proud to share the experiences of these companies in connecting with ACT-AEC’s consortium partners. To connect with ACT-AEC, contact us.

Twitter Youtube Linkedin

Canadian Biotech Opportunity

July 16, 2024 No Comments

Click here for a full summary of the ACT October Meeting In preparation for the Third ACT Consortium Meeting, we are seeking Canadian biotechnology companies

Read More »

ACT-AEC First Annual Meeting

November 10, 2023 No Comments

At the ACT-AEC First Annual Meeting, ACT-AEC invited 48 Canadian biotechnology companies to present their work to members of the consortium. ACT-AEC is proud to

Read More »

The Accelerating Clinical Trials Consortium is generously supported through multi-year funding from the Canadian Institutes of Health Research’s Clinical Trials Fund, as part of Canada’s Biomanufacturing and Life Sciences Strategy to ensure that Canadians are well served by a national clinical trials network.